PROCR and peripheral arterial disease: To explore the usefulness of soluble EPCR shed from endothelial cells into the circulating blood as a potential biomarker of endothelial function and angiogenic potential, patients with PAD stage II were prospectively recruited and compared to age- and sex-matched healthy individuals, with or without cardiovascular risk factors, or to PAD stage III/IV patients.